A Master Protocol to Evaluate Biomarker-Driven Therapies and Immunotherapies in Previously-Treated Non-Small Cell Lung Cancer (Lung-MAP Screening Study)
Principal Investigator: Dr. Theodore Thomas
The primary objective of this screening study is to test patient specimens to determine eligibility for participation in the biomarker-driven and non-matched sub-studies included within the Lung-MAP umbrella protocol.
This study is currently enrolling. To learn more about LUNG MAP and how you can join contact our research office at (314) 289-7690.
This study is funded by the Foundation through the National Cancer Institute (NCI)
The primary objective of this screening study is to test patient specimens to determine eligibility for participation in the biomarker-driven and non-matched sub-studies included within the Lung-MAP umbrella protocol.
This study is currently enrolling. To learn more about LUNG MAP and how you can join contact our research office at (314) 289-7690.
This study is funded by the Foundation through the National Cancer Institute (NCI)